News and Insights of 3D Printing and Manufacturing
A 3D printed patch designed to promote heart muscle regeneration is being developed by a bioengineering professor at the University of Texas at Arlington (UTA). This project aims to address a critical medical challenge by offering a potential new treatment option for heart attack survivors, whose damaged heart tissue currently lacks the ability to repair itself—often leading to serious, long-term health complications.
Health Canada, the federal regulatory authority, has approved U.S. medical device startup Nanochon’s clinical trial design, authorizing the launch of a first-in-human study for its 3D printed Chondrograft knee implant. The trial will assess the implant’s ability to repair damaged cartilage and reduce recovery times for patients with limited treatment options. This approval represents a significant step forward in validating Nanochon’s minimally invasive joint repair technology.
Want to speak at AMA: Energy 2025 or AMA: Automotive & Mobility 2025? Submit your application now!
Want to speak at AMA: Energy 2025 or AMA: Automotive & Mobility 2025? Submit your application now!
Hong Kong based Centre for Immunology & Infection Limited (C2i), its spin-off C2iTech, and Japanese multinational conglomerate Hitachi have announced a strategic collaboration to develop 3D printed airway organoids for clinical applications. C2i also unveiled Hong Kong’s first automated organoid culture system, located at the Hong Kong Science Park (HKSTP). These joint efforts aim to enhance the efficiency, scalability, and standardization of organoid production, driving advancements in personalized medicine and regenerative therapies.
Secure your spot now for exclusive AM insights at our Additive Manufacturing Advantage online conference covering aerospace, space, and defense!
Secure your spot now for exclusive AM insights at our Additive Manufacturing Advantage online conference covering aerospace, space, and defense!
Secure your spot now for exclusive AM insights at our Additive Manufacturing Advantage online conference covering aerospace, space, and defense.
U.S.-based 3D printer manufacturer 3D Systems, in partnership with French MedTech firm TISSIUM, has secured FDA approval for a bioabsorbable, 3D printed device designed to treat peripheral nerve damage. This approval validates the polymer’s clinical effectiveness and paves the way for its use across a wide range of medical treatments.
Dimension Ortho, a provider of 3D printed orthotics, has entered into a partnership with Rothman Orthopaedics, a major U.S.-based orthopedic practice recognized for its work in musculoskeletal care. This collaboration will enable Rothman to implement Dimension Ortho’s platform for customized bracing and fracture care across its clinical network, with the goal of elevating patient care standards.